Plasma HDL levels highly correlate with cognitive function in exceptional longevity

Journals of Gerontology - Series A Biological Sciences and Medical Sciences

Volumn 57, Issue 11, 2002, Pages

  Atzmon, Gil ^a   Gabriely, Ilan ^a   Greiner, William ^a   Davidson, Deborah ^a   Schechter, Clyde ^a   Barzilai, Nir ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN A1; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

AGED; AGING; ARTICLE; BODY MASS; CHOLESTEROL BLOOD LEVEL; COGNITION; COGNITIVE DEFECT; CONTROLLED STUDY; COVARIANCE; FEMALE; HUMAN; HYDRATION; JEW; LIPID METABOLISM; LONGEVITY; MALE; MINI MENTAL STATE EXAMINATION; MULTIPLE REGRESSION; NORMAL HUMAN; NUTRITIONAL STATUS; PRIORITY JOURNAL; SEX DIFFERENCE; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 0036846496     PISSN: 10795006     EISSN: None     Source Type: Journal    
DOI: 10.1093/gerona/57.11.M712     Document Type: Article

References (24)

1. Barzilai N, Shuldiner AR. Searching for human longevity genes: The future history of gerontology in the post-genomic era. J Gerontol Med Sci. 2001;56A:M83-M87..
2. Perls TT, Bubrick E, Wager CG, Vijg J, Kruglyak L. Siblings of centenarians live longer. Lancet. 1998;351:1560.
3. Puca AA, Daly MJ, Brewster SJ, et al. A genome-wide scan for linkage to human exceptional longevity identifies a locus on chromosome 4. Proc Natl Acad Sci USA. 2001;9:10505-10508.
4. Barzilai N, Gabriely I, Gabriely M, Jankowitz N, Sorkin JD. Offspring of centenarians have a favorable lipid profile. J Am Geriatr Soc. 2001;49:76-79.
5. Wilson PWF, Keaven M, Anderson M, Harris T, Kannel WB, Castelli WP. Determinants of change in total cholesterol and HDL-C with age: The Framingham study. J Gerontol Med Sci. 1994;49:M252-M257.
6. Merched A, Xia Y, Visvikis S, Serot JM, Siest G. Decreased high-density lipoprotein cholesterol and serum apolipoprotein A-I concentrations are highly correlated with the severity of Alzheimer's disease. Neurobiol Aging. 2000;21:27-30.
7. Kawano M, Kawakami M, Otsuka M, Yashima H, Yaginuma T, Ueki A. Marked decrease of plasma apolipoprotein A-I and A-II in Japanese patients with late-onset non-familial Alzheimer's disease (letter). Clin Chim Acta. 1995;239:209-211.
8. Kuriyama M, Takahashi K, Yamono T, et al. Low levels of serum apolipoprotein a1 and a2 in senile dementia. Jpn J Psychiatry Neurol. 1994;48:589-593.
9. Folstein MF, Folstein SE, McHugh PR. "Mini-mental state": A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12:189-198.
10. Austin MA, Ordaves JM, Eckfeldt JH, et al. Guidelines of the National Heart, Lung, and Blood Institute Working Group on blood drawing, processing, and storage for genetic studies. Am J Epidemiol. 1996;144:437-441.
11. Corti MC, Guralnik JM, Salive ME, et al. PLASMA HDL cholesterol predicts coronary heart disease mortality in older persons. JAMA. 1995;274:539-544.
12. Weijenberg MP, Feskens EJM, Kromhout D. Total and high density lipoprotein cholesterol as a risk factor for coronary heart disease in elderly men during 5 years of follow-up: The Zutphen Study. Am J Epidemiol. 1996;143:151-158.
13. Luoma PV. Gene activation, apolipoprotein AI/high density lipoprotein, atherosclerosis prevention and longevity. Pharmacol Toxicol. 1997;81:57-64.
14. Barbagallo CM, Averna MR, Frada G, Noto D, Cavera G, Notarbartolo A. Lipoprotein profile and high-density lipoproteins: Subfractions distribution in centenarians. Gerontology. 1998;44:106-110.
15. Bates ER. Raising high-density lipoprotein cholesterol and lowering low-density lipoprotein cholesterol as adjunctive therapy to coronary artery revascularization. Am J Cardiol. 2000;86:28L-34L.
16. Bondjers G, Gustafson A, Kral J, Schersten T, Sjostrom L. Cholesterol content in arterial tissue in relation to serum lipoproteins in humans. Artery. 1976;2:200-207.
17. Burke GL, Arnold AM, Bild DE, et al. Factors associated with healthy aging: The Cardiovascular Health Study. J Am Geriatr Soc. 2001;49:254-262.
18. Perls T, Levenson R, Regan M, Puca A. What does it take to live to 100? Mech Ageing Dev. 2002;123(2-3):231-242.
19. U.S. Department of Health and Human Services, National Center for Health Statistics. Third National Health and Nutrition Survey, 1988-1994, NHANES III Second Laboratory Data File [CD-ROM series 11, No. 2A]. Hyattsville, MD: Centers for Disease Control and Prevention: 1998.
20. Torre JC, Stefano GB. Evidence that Alzheimer's disease is a microvascular disorder: The role of constitutive nitric oxide. Brain Res Rev. 2000;34:119-136.
21. Griffin JH, Kojima K, Banka CL, Curtiss LK, Fernandez JA. High-density lipoprotein enhancement of anticoagulant activities of plasma protein S and activated protein C. J Clin Invest. 1999;103(2):219-227.
22. Berliner JA, Navab M, Fogelman AM, et al. Atherosclerosis: Basic mechanisms. Oxidation, inflammation, and genetics. Circulation. 1995; 91(9):2488-2496.
23. Xia P, Vadas MA, Rye KA, Barter PJ, Gamble JR. High density lipoproteins (HDL) interrupt the sphingosine kinase signaling pathway. A possible mechanism for protection against atherosclerosis by HDL. J Biol Chem. 1999;274(46):33143-33147.
24. Koudinov A, Matsubara E, Frangione B, Ghiso J. The soluble form of Alzheimer's amyloid beta protein is complexed to high density lipoprotein 3 and very high density lipoprotein in normal human plasma. Biochem Biophys Res Commun. 1994;205(2):1164-1171.